Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Cash from Financing Activities (2016 - 2026)

Protara Therapeutics' Cash from Financing Activities history spans 13 years, with the latest figure at $1.1 million for Q1 2026.

  • Quarterly Cash from Financing Activities fell 33.87% to $1.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $82.1 million through Mar 2026, down 42.03% year-over-year, with the annual reading at $82.7 million for FY2025, 40.86% down from the prior year.
  • Cash from Financing Activities came in at $1.1 million for Q1 2026, down from $81.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $97.8 million in Q4 2024 to a low of -$76000.0 in Q1 2024.
  • The 5-year median for Cash from Financing Activities is $10500.0 (2025), against an average of $18.6 million.
  • The largest YoY upside for Cash from Financing Activities was 2376.32% in 2025 against a maximum downside of 99.98% in 2025.
  • Protara Therapeutics' Cash from Financing Activities stood at -$18000.0 in 2022, then plummeted by 50.0% to -$27000.0 in 2023, then surged by 362503.7% to $97.8 million in 2024, then dropped by 17.26% to $81.0 million in 2025, then crashed by 98.59% to $1.1 million in 2026.
  • Per Business Quant, the three most recent readings for TARA's Cash from Financing Activities are $1.1 million (Q1 2026), $81.0 million (Q4 2025), and $13000.0 (Q3 2025).